|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-10-30
|
|
pubmed:abstractText |
Our aim was to assess and compare the long-term effect of interferon at standard (6 months) and reinforced dose and duration regimens in chronic hepatitis C.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:BaillyFF,
pubmed-author:BarangeKK,
pubmed-author:Bartolomei-PortalII,
pubmed-author:BastieAA,
pubmed-author:ChastangCC,
pubmed-author:Chaumet-RiffaudPP,
pubmed-author:ChevretSS,
pubmed-author:DauratVV,
pubmed-author:DegosFF,
pubmed-author:GaynoSS,
pubmed-author:MoussalliJJ,
pubmed-author:NaveauSS,
pubmed-author:RiachiGG
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
224-32
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9722203-Adult,
pubmed-meshheading:9722203-Aged,
pubmed-meshheading:9722203-Alanine Transaminase,
pubmed-meshheading:9722203-Antiviral Agents,
pubmed-meshheading:9722203-Clinical Protocols,
pubmed-meshheading:9722203-DNA, Viral,
pubmed-meshheading:9722203-Drug Administration Schedule,
pubmed-meshheading:9722203-Female,
pubmed-meshheading:9722203-Follow-Up Studies,
pubmed-meshheading:9722203-France,
pubmed-meshheading:9722203-Genotype,
pubmed-meshheading:9722203-Hepacivirus,
pubmed-meshheading:9722203-Hepatitis C, Chronic,
pubmed-meshheading:9722203-Hepatitis C Antibodies,
pubmed-meshheading:9722203-Humans,
pubmed-meshheading:9722203-Interferon-alpha,
pubmed-meshheading:9722203-Liver Cirrhosis,
pubmed-meshheading:9722203-Male,
pubmed-meshheading:9722203-Middle Aged,
pubmed-meshheading:9722203-Polymerase Chain Reaction,
pubmed-meshheading:9722203-Probability,
pubmed-meshheading:9722203-Recombinant Proteins,
pubmed-meshheading:9722203-Time Factors
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 Group.
|
|
pubmed:affiliation |
Service d'Hépatogastroentérologie, Hôpital Beaujon, Clichy, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
